Canaccord Genuity Reiterates Hold on AspenBio Pharma (APPY)

By admin | 6 years ago

AspenBio Pharma (NASDAQ: APPY)‘s stock had its “hold” rating reiterated by investment analysts at Canaccord Genuity in a note issued to investors on Friday.

Shares of AspenBio Pharma traded up 2.41% during mid-day trading on Friday, hitting $0.4895. AspenBio Pharma has a one year low of $0.40 and a one year high of $3.80. The company’s market cap is $4.7 million.

AspenBio Pharma, Inc. (AspenBio) is a bio-pharmaceutical company dedicated to the discovery, development, manufacture, and marketing of products.

About the author